Gut Microbiota and Alzheimer's Disease: How to Study and Apply Their Relationship

Area of Science:

• Neuroscience
• Microbiology
• Gastroenterology

Background:

• The gut microbiota (GM) plays a crucial role in maintaining brain homeostasis through the microbiota-gut-brain axis (MGBA).
• Alterations in GM composition are increasingly linked to neurological disorders, notably Alzheimer's disease (AD).

Purpose of the Study:

• To review the concept of the MGBA and its influence on AD development and progression.
• To present experimental methodologies for investigating GM's role in AD pathogenesis.
• To discuss potential therapeutic strategies targeting the MGBA for AD treatment.

Main Methods:

• Literature review of studies on the microbiota-gut-brain axis and Alzheimer's disease.
• Analysis of experimental approaches used to study GM in AD.
• Synthesis of current research on MGBA-based therapeutic strategies.

Main Results:

• The MGBA is a significant factor in AD pathology, offering insights into disease mechanisms.
• Various experimental methods are available to explore the GM-AD relationship.
• Targeting the MGBA presents promising avenues for novel AD therapies.

Conclusions:

• The MGBA is a critical area for understanding and treating Alzheimer's disease.
• Further research into GM modulation holds potential for effective AD interventions.
• This review provides a foundational understanding for practical applications in AD research and therapy.